Published in Dev Biol on November 01, 1988
TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol (2001) 3.22
Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol (1990) 2.19
Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation. Iowa Orthop J (1995) 1.60
Interaction of TGFβ and BMP signaling pathways during chondrogenesis. PLoS One (2011) 1.13
Osteogenic gene expression correlates with development of heterotopic ossification in war wounds. Clin Orthop Relat Res (2013) 1.07
Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms. Am J Pathol (1997) 0.95
Expression of mRNAs coding for the alpha 1 chain of type XIII collagen in human fetal tissues: comparison with expression of mRNAs for collagen types I, II, and III. J Cell Biol (1989) 0.93
The effect of tissue decalcification on mRNA retention within bone for in-situ hybridization studies. Int J Exp Pathol (1993) 0.92
Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3. Am J Hum Genet (2000) 0.90
Induction of an osteocyte-like phenotype by fibroblast growth factor-2. Biochem Biophys Res Commun (2010) 0.87
Type IV collagen mRNA accumulates in the mesenchymal compartment at early stages of murine developing intestine. J Cell Biol (1990) 0.85
TGFβ signaling in cartilage development and maintenance. Birth Defects Res C Embryo Today (2014) 0.85
Vitamin D and microRNAs in bone. Crit Rev Eukaryot Gene Expr (2013) 0.83
Tumor cells of malignant fibrous histiocytomas express mRNA for laminin. Am J Pathol (1991) 0.81
Multifaceted signaling regulators of chondrogenesis: Implications in cartilage regeneration and tissue engineering. Genes Dis (2015) 0.80
c-fos oncogene underexpression in salivary gland tumors as measured by in situ hybridization. Am J Pathol (1993) 0.77
Predisposition to familial osteoarthrosis linked to type II collagen gene. Lancet (1989) 2.43
Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by in situ hybridization. J Cell Biol (1987) 2.41
Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol (1994) 2.12
A standardized experimental fracture in the mouse tibia. J Orthop Res (1993) 1.75
The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am J Pathol (1998) 1.68
Mouse type II collagen gene. Complete nucleotide sequence, exon structure, and alternative splicing. J Biol Chem (1991) 1.67
Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. Biochim Biophys Acta (1991) 1.67
Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Clin Cancer Res (2000) 1.63
Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest (1994) 1.62
Stage-and tissue-specific expression of a Col2a1-Cre fusion gene in transgenic mice. Matrix Biol (2001) 1.55
Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn (1997) 1.44
Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen alpha 1-chain gene. Proc Natl Acad Sci U S A (1991) 1.37
Construction and partial characterization of two recombinant cDNA clones for procollagen from chicken cartilage. Nucleic Acids Res (1982) 1.35
Coordinated regulation of type I and type III collagen production and mRNA levels of pro alpha 1(I) and pro alpha 2(I) collagen in cultured morphea fibroblasts. Arch Dermatol Res (1987) 1.35
The mouse collagen X gene: complete nucleotide sequence, exon structure and expression pattern. Biochem J (1993) 1.28
Normal long bone growth and development in type X collagen-null mice. Nat Genet (1994) 1.26
Interleukin-1 increases collagen production and mRNA levels in cultured skin fibroblasts. Biochim Biophys Acta (1987) 1.25
Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones. Development (1988) 1.25
Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. J Invest Dermatol (1988) 1.21
A metaphyseal defect model of the femur for studies of murine bone healing. Bone (2001) 1.19
Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett (1996) 1.18
Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of pro alpha 1(II) collagen chain. J Cell Biol (1992) 1.16
Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. J Pathol (2001) 1.16
High resolution of a small pericentric inversion of chromosome 11. J Med Genet (1980) 1.14
Characterization of trimethoprim resistance by use of probes specific for transposon Tn7. Antimicrob Agents Chemother (1984) 1.10
Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci U S A (1996) 1.10
Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney. Am J Pathol (1997) 1.09
Construction of a human pro alpha 1(III) collagen cDNA clone and localization of type III collagen expression in human fetal tissues. Matrix (1989) 1.08
The novel type II prolyl 4-hydroxylase is the main enzyme form in chondrocytes and capillary endothelial cells, whereas the type I enzyme predominates in most cells. J Biol Chem (1998) 1.06
Developmental expression of a type II collagen/beta-galactosidase fusion gene in transgenic mice. Dev Dyn (1995) 1.06
Role of cathepsin K in normal joints and in the development of arthritis. Curr Drug Targets (2007) 1.06
Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K. J Bone Miner Res (2001) 1.05
Comparative analysis of the distribution of laminin chains in the basement membranes in some malignant epithelial tumors: the alpha1 chain of laminin shows a selected expression pattern in human carcinomas. J Histochem Cytochem (2001) 1.05
72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. J Histochem Cytochem (1994) 1.05
Expression of the laminin gamma 2 chain in pancreatic adenocarcinoma. J Pathol (1996) 1.05
Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol (1991) 1.05
Human pro alpha 1(I) collagen: cDNA sequence for the C-propeptide domain. Nucleic Acids Res (1988) 1.04
Localization of type I and III collagen and fibronectin production in injured gastrocnemius muscle. Lab Invest (1991) 1.04
Expression of Sox9 and type IIA procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis. Arthritis Rheum (2001) 1.03
Assembly of cartilage collagen fibrils is disrupted by overexpression of normal type II collagen in transgenic mice. Proc Natl Acad Sci U S A (1993) 1.02
Expression of the laminin gamma2 chain in different histological types of lung carcinoma. A study by immunohistochemistry and in situ hybridization. J Pathol (1999) 1.02
Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in augmentation of bone defect healing. J Biomed Mater Res (1997) 1.01
Increased type I collagen mRNA levels in cultured scleroderma fibroblasts. Biochim Biophys Acta (1984) 1.01
Analysis of aggrecan and tenascin gene expression in mouse skeletal tissues by northern and in situ hybridization using species specific cDNA probes. Biochim Biophys Acta (1994) 1.01
Identification of messenger RNA for human type II collagen. FEBS Lett (1984) 1.01
Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells. Eur J Cancer (2000) 1.00
Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis. Arthritis Rheum (2000) 0.99
Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am J Pathol (1993) 0.99
Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines. Br J Cancer (1994) 0.98
Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J Invest Dermatol (1993) 0.97
Expression of mRNAs for collagens and other matrix components in dedifferentiating and redifferentiating human chondrocytes in culture. FEBS Lett (1989) 0.96
Synthesis of underpolymerized hyaluronic acid by fibroblasts cultured from rheumatoid and non-rheumatoid synovitis. Rheumatol Int (1982) 0.96
Conservation of the sizes of 53 introns and over 100 intronic sequences for the binding of common transcription factors in the human and mouse genes for type II procollagen (COL2A1). Biochem J (1995) 0.96
Expression of the myc proto-oncogenes in developing human fetal brain. Oncogene (1990) 0.95
Cathepsin expression during skeletal development. Biochim Biophys Acta (1999) 0.95
Determination of the single polyadenylation site of the human pro alpha 1(II) collagen gene. Nucleic Acids Res (1987) 0.95
Regulation of extracellular matrix genes during fracture healing in mice. Clin Orthop Relat Res (1993) 0.94
Structural analysis of the regulatory elements of the type-II procollagen gene. Conservation of promoter and first intron sequences between human and mouse. Biochem J (1992) 0.94
Coordinate patterns of expression of type I and III collagens during mouse development. Matrix Biol (1995) 0.94
Distribution of type XV collagen transcripts in human tissue and their production by muscle cells and fibroblasts. Am J Pathol (1995) 0.93
Activation of type I collagen genes in cultured scleroderma fibroblasts. J Cell Biochem (1985) 0.93
Elevated pro alpha 2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding gene. FEBS Lett (1987) 0.93
Expression of mRNAs coding for the alpha 1 chain of type XIII collagen in human fetal tissues: comparison with expression of mRNAs for collagen types I, II, and III. J Cell Biol (1989) 0.93
Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus. Calcif Tissue Int (2000) 0.93
Type X collagen, a natural component of mouse articular cartilage: association with growth, aging, and osteoarthritis. Arthritis Rheum (1998) 0.92
Lifelong voluntary joint loading increases osteoarthritis in mice housing a deletion mutation in type II procollagen gene, and slightly also in non-transgenic mice. Ann Rheum Dis (2002) 0.92
In situ localization of collagen production by chondrocytes and osteoblasts in fracture callus. J Bone Joint Surg Am (1989) 0.92
Production of membrane-type matrix metalloproteinase-1 (MT-MMP-1) in early human placenta. A possible role in placental implantation? J Histochem Cytochem (1998) 0.92
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas. APMIS (2001) 0.92
Autoimmune recognition of cartilage collagens. Ann Med (1993) 0.91
Construction and identification of a cDNA clone for human type II procollagen mRNA. Biochem J (1985) 0.91
Evidence for insufficient chondrocytic differentiation during repair of full-thickness defects of articular cartilage. Matrix Biol (1996) 0.91
Epidermal growth factor increases collagen production in granulation tissue by stimulation of fibroblast proliferation and not by activation of procollagen genes. Biochem J (1987) 0.90
Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model. J Bone Miner Res (1999) 0.90
Growth-dependent modulation of type I collagen production and mRNA levels in cultured human skin fibroblasts. Biochim Biophys Acta (1990) 0.90
Age-dependent changes in the expression of matrix components in the mouse eye. Exp Eye Res (2001) 0.90
Prolyl 4-hydroxylase isoenzymes I and II have different expression patterns in several human tissues. J Histochem Cytochem (2001) 0.90
Comparison on collagen gene expression in the developing chick embryo tendon and heart. Tissue and development time-dependent action of dexamethasone. Biochim Biophys Acta (1991) 0.90
Abnormal adherence junctions in the heart and reduced angiogenesis in transgenic mice overexpressing mutant type XIII collagen. EMBO J (2001) 0.89
Altered distribution and synthesis of laminin-5 (kalinin) in oral lichen planus, epithelial dysplasias and squamous cell carcinomas. Br J Dermatol (1997) 0.89
Immunohistochemical evidence that lung carcinomas grow on alveolar basement membranes. Am J Surg Pathol (1990) 0.89
The N-myc proto-oncogene and IGF-II growth factor mRNAs are expressed by distinct cells in human fetal kidney and brain. J Cell Biol (1989) 0.89
Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea. J Rheumatol (1991) 0.89
Type I collagen messenger RNA levels in experimental granulation tissue and silicosis in rats. Med Biol (1986) 0.89
Differential expression of fibrillar collagen genes during callus formation. Biochem Biophys Res Commun (1987) 0.88
Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies. Int J Cancer (1993) 0.87
Polymorphic restriction sites of type II collagen gene: their location and frequencies in the Finnish population. Hum Hered (1988) 0.87
Characterization of recombinant human type IX collagen. Association of alpha chains into homotrimeric and heterotrimeric molecules. J Biol Chem (1999) 0.87
Distinct expression of type XIII collagen in neuronal structures and other tissues during mouse development. Matrix Biol (2001) 0.86
Accelerated up-regulation of L-Sox5, Sox6, and Sox9 by BMP-2 gene transfer during murine fracture healing. J Bone Miner Res (2001) 0.86
Location and alternative splicing of type XIII collagen RNA in the early human placenta. Lab Invest (1993) 0.86
Immunoelectron microscopic localization of laminin, type IV collagen, and type III pN-collagen in reticular fibers of human lymph nodes. J Histochem Cytochem (1989) 0.86
Localization of osteonectin expression in human fetal skeletal tissues by in situ hybridization. Calcif Tissue Int (1989) 0.86
Renal pathology of fetuses with congenital nephrotic syndrome of the Finnish type. A qualitative and quantitative light microscopic study. Nephron (1981) 0.85
Cysteine proteinases in chondrosarcomas. Matrix Biol (2001) 0.85
Specific hybridization probes for mouse alpha 2(IX) and alpha 1(X) collagen mRNAs. Biochim Biophys Acta (1992) 0.85
Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis. Br J Haematol (1986) 0.85